Get started
RESMED INCRESMED INCRESMED INC

RESMED INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast

1RMD chart


Full chart

1RMD upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪31.87 B‬ EUR
Dividend yield (indicated)
0.86%
Price to earnings Ratio (TTM)
27.7
Basic EPS (TTM)
8.3 EUR
Net income (FY)
‪953.16 M‬ EUR
Revenue (FY)
‪4.37 B‬ EUR
Shares float
‪145.58 M‬
Beta (1Y)
0.71

Employees


Employees (FY)
‪9.98 K‬
Change (1Y)
−160 −1.58%
Revenue / Employee (1Y)
‪438.30 K‬ EUR
Net income / Employee (1Y)
‪95.51 K‬ EUR

About ResMed Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Michael J. Farrell
Website
resmed.com
Headquarters
San Diego
Founded
1989
FIGI
BBG01TNWKMT7
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

1RMD news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Check out other big names from the same industry as 1RMD.

Frequently Asked Questions


The current price of 1RMD is 217.7 EUR — it has increased by 0.14% in the past 24 hours. Watch RESMED INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange RESMED INC stocks are traded under the ticker 1RMD.
1RMD stock has fallen by −0.18% compared to the previous week, the month change is a 4.87% rise, over the last year RESMED INC has showed a 4.87% increase.
We've gathered analysts' opinions on RESMED INC future price: according to them, 1RMD price has a max estimate of 279.33 EUR and a min estimate of 177.31 EUR. Watch 1RMD chart and read a more detailed RESMED INC stock forecast: see what analysts think of RESMED INC and suggest that you do with its stocks.
1RMD reached its all-time high on May 16, 2025 with the price of 224.1 EUR, and its all-time low was 206.6 EUR and was reached on Apr 29, 2025. View more price dynamics on 1RMD chart.
See other stocks reaching their highest and lowest prices.
1RMD stock is 0.14% volatile and has beta coefficient of 0.71. Track RESMED INC stock price on the chart and check out the list of the most volatile stocks — is RESMED INC there?
Today RESMED INC has the market capitalization of ‪31.78 B‬, it has increased by 0.16% over the last week.
Yes, you can track RESMED INC financials in yearly and quarterly reports right on TradingView.
RESMED INC is going to release the next earnings report on Jul 31, 2025. Keep track of upcoming events with our Earnings Calendar.
1RMD earnings for the last quarter are 2.19 EUR per share, whereas the estimation was 2.20 EUR resulting in a −0.35% surprise. The estimated earnings for the next quarter are 2.19 EUR per share. See more details about RESMED INC earnings.
RESMED INC revenue for the last quarter amounts to ‪1.19 B‬ EUR, despite the estimated figure of ‪1.19 B‬ EUR. In the next quarter, revenue is expected to reach ‪1.17 B‬ EUR.
1RMD net income for the last quarter is ‪337.42 M‬ EUR, while the quarter before that showed ‪332.90 M‬ EUR of net income which accounts for 1.36% change. Track more RESMED INC financial stats to get the full picture.
Yes, 1RMD dividends are paid quarterly. The last dividend per share was 0.47 EUR. As of today, Dividend Yield (TTM)% is 0.85%. Tracking RESMED INC dividends might help you take more informed decisions.
RESMED INC dividend yield was 1.00% in 2024, and payout ratio reached 27.75%. The year before the numbers were 0.81% and 28.91% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 29, 2025, the company has ‪9.98 K‬ employees. See our rating of the largest employees — is RESMED INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RESMED INC EBITDA is ‪1.69 B‬ EUR, and current EBITDA margin is 34.16%. See more stats in RESMED INC financial statements.
Like other stocks, 1RMD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RESMED INC stock right from TradingView charts — choose your broker and connect to your account.